Category - GHP News

GHP News Latest Science

ViVa news – week 13

WHO kicks off World Immunization Week 2026 campaign messaging WHO has rolled out the 2026 World Immunization Week materials under a very on‑brand call to action: “Your decision makes a difference. Immunization for all,”...

2 April, 2026

12 min read

GHP News Latest Science

Vietnam: Early 2026 surge in hand, foot and mouth disease

In the first quarter of 2026, Vietnam experienced a marked resurgence of hand, foot and mouth disease (HFMD), with reported cases exceeding 25,000 and a concurrent increase in severe outcomes, including four deaths...

2 April, 2026

4 min read

GHP News Latest Science

Lymeborreliosis

Lyme borreliosis is a zoonotic tick-borne bacterial disease caused by several species within the Borrelia burgdorferi sensu lato complex, transmitted to humans by ticks of the Ixodes ricinus complex and characterized by...

2 April, 2026

19 min read

GHP News Latest Science

OspA-Based 6 valent Lyme vaccine shows >70% efficacy in phase 3 VALOR trial across individuals aged 5 years and older

Pfizer and Valneva announced topline Phase 3 VALOR data for their investigational 6‑valent OspA-based Lyme disease vaccine candidate PF‑07307405 (LB6V), reporting more than 70% efficacy in preventing Lyme disease in...

2 April, 2026

4 min read

GHP News Infographic

mRNA vaccines: from sequence to shot

Download Infographic Overview The concept of mRNA as a vaccine platform has evolved over several decades, using host cells to produce antigens. mRNA vaccines can induce both B cell and T cell immune responses and avoid...

25 March, 2026

1 min read

GHP News Latest Science

Global polio eradication and current outbreaks

Wild poliovirus (WPV1) Endemic transmission of WPV1 persists only in Afghanistan and Pakistan, which together form a single epidemiologic block.1-3 For 2025, WHO’s IHR Emergency Committee cites 40 WPV1 cases (9...

25 March, 2026

4 min read

GHP News Latest Science

Myocarditis and mRNA COVID-19 vaccines 2026: signal, data, and interpretation

In 2021, surveillance systems in multiple countries detected a safety signal for myocarditis and pericarditis after mRNA COVID‑19 vaccination, particularly in adolescent and young adult males. Three years later, the...

25 March, 2026

8 min read

GHP News Latest Science

Global and regional updates on COVID-19 vaccines–associated myocarditis

Global / Multicontinental COVID-19 vaccine myocarditis signal: updated interpretation CIDRAP summarises current evidence that the early myocarditis signal with mRNA COVID-19 vaccines in young males was real but now...

25 March, 2026

2 min read

GHP News Latest Science

Clostridioides difficile vaccines: one step back, two steps forward

After years of disappointments, the C. difficile vaccine field is quietly repositioning itself. While GSK has officially dropped its own toxoid candidate from the pipeline, at least two other toxin‑based approaches—one...

25 March, 2026

5 min read

GHP News Latest Science

Evidence brief -Week 12

Brazil develops and rolls out single-dose dengue vaccine This article signals a major advance toward operationally feasible dengue vaccination, especially in high-burden, access constrained settings, and may preview...

25 March, 2026

20 min read